- How NYU Langone built 1 of the nation’s fastest-growing GI divisions
- BCBS study: Hospital AI billing tools may be driving up healthcare costs by billions
- The transition gap: How RCA is using recovery housing to prevent relapse
- CMS moves forward with 3rd round of Medicare drug negotiations
- Kroger pharmacies add Zepbound KwikPen
- Nurses navigate AI-generated health information at bedside
- Louisiana senator resumes push to repeal water fluoridation program
- HCA’s highest-earning executives in 2025
- HCA’s highest-earning executives in 2025
- CHS Alabama hospital CEO heads to Florida
- RWJBarnabas New Jersey hospital taps new COO
- Why some health system CEOs are opting out of cross-market expansion
- Stanford Health Care leader to advise agentic AI startup
- Piedmont, Encompass tap CEO for planned Georgia hospital
- Inside Virginia’s 1st ‘tri-accredited’ bariatric surgery center
- The red flags DSOs can’t afford to ignore
- About 82% of public Medicare Advantage rate notice comments tied to ‘dark money’ group: KFF
- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- The uneven competition in physician markets
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- Oceans Behavioral Hospital debuts virtual outpatient program
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- 30+ dental industry updates in California, Florida and Texas
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- Georgia health system launches new digital patient billing system
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- How nursing backgrounds shaped 2 revenue cycle leaders
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Hospital margins take a dive
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Medicare Advantage spending 14% higher than fee for service: Report
- Washington hospital to close pediatric rehab clinic
- New Jersey system partners with health center ahead of ED closure
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Genetic Test May Predict Leukemia Relapse Risk
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- NYU Stern report calls for private equity reforms to safeguard quality of care
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
LARA's licensing process is heavily weighted on the entry side, with very little real supervision after licensing. Dr. Farid T. Fata should never have been licensed in Michigan, and his license should have been revoked well before his arrest in 2013.
An experienced oncology nurse, Angela Swantek, interviewed at Dr. Fata's Michigan Hematology-Oncology (MHO) in 2010 and saw practices that were "plain wrong". Ms. Swantek was convinced that MHO was drugging patients solely to bill their insurance companies for extravagant fees. She filed a complaint with LARA, but got no response until 2011, when LARA sent her a form letter saying that there was no evidence to support an investigation into Fata. An MHO office manager, George Karadsheh, echoed Ms. Swantek's allegations in 2013, finally leading to Dr. Fata's arrest:
https://thecinemaholic.com/farid-fata-where-is-the-fraudster-now/
Farid Fata: Where is the Fraudster Now?
By Sounak Sengupta - June 17, 2023NBC’s ‘Dateline: Do No Harm’ follows the criminal antiques of fraudster, Dr. Farid Fata, as he was convicted of medical malpractice and other charges in August 2013 in Michigan. Rather than treating or easing the suffering of his cancer patients, he administered a combination of chemical infusions and injections with potentially harmful and deadly side effects for his financial benefit. So, how was Farid caught, and where is he now? Let’s find out.
Who is Farid Fata?
Farid T. Fata was born to a Melkite Catholic family in Lebanon in 1965. He secured a medical degree in his native country in 1992 before migrating to the United States to pursue a career in medical science. He served a residency at Maimonides Medical Center in Brooklyn, New York, from 1993 to 1996 and then as a fellow in hematology-oncology at Memorial Sloan Kettering Cancer Center in Manhattan until 1999. Farid worked as an attending physician at Geisinger Medical Center in Danville, Pennsylvania, from 2000 to 2003.
He opened his solely owned practice, Michigan Hematology-Oncology (MHO), at 543 North Main Street in 2003 in Rochester Hills, Michigan. What started as a small, single physician office expanded over the following decade and grew to six more locations — Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park. Farid became a naturalized U.S. citizen in April 2009. By the time he was arrested in 2013, MHO had 16,000 historical patients and 1,700 current patients — the vast majority of whom belonged to Farid.
Court records underlined how he accomplished this astonishing growth using several means. His business documents and employee testimonies state Farid was seeing as many as 50-60 patients per day, scheduled in eight-minute increments. He employed non-licensed physicians with medical degrees from foreign countries to work them up before he saw them for five-ten minutes, billing at the two highest levels for office visits. Patients waited for hours at a time before they were ushered in.
According to an oncology supply company representative supplying most of his drugs, Farid worked on a plan to compete with large practices. His medicine orders skyrocketed in a year to over $7 million, then $16 million. He ordered in bulk at the end of quarters to reach the threshold for contractual discounts. Reports stated an average doctor in an oncology practice purchases approximately $1.5 million of drugs in a given year. However, when he was arrested, MHO bought $45 million for only three doctors.
A sentencing memorandum stated how Farid expanded his businesses to include a radiation treatment center, Michigan Radiation Institute (MRI); an in-house pharmacy at MHO’s Rochester Hills location, Vital Pharmacare (Vital); a diagnostic testing facility, United Diagnostics; and a charity located at MHO and staffed by social workers and grant writers, Swan for Life. Farid specialized in treating blood cancer and earned a sterling reputation as one of the best cancer specialists in the Detroit area.
According to the episode, he created a niche for himself with his aggressive treatment procedures that involved giving higher doses of chemotherapy drugs more frequently — he termed it the “European protocol.” Farid’s erstwhile wife, Samar, helped run the business side of his practice as Chief Executive Officer and Chief Financial Officer of his companies. According to an ensuing investigation, the federal officers termed Farid the most egregious fraudster in the history of this country.
Where is Farid Fata Now?
His misdemeanors were not solely limited to the millions of dollars he stole but also the harm he inflicted on more than 500 patients. Some of Farid’s misdemeanors include deliberately misdiagnosing patients with multiple myeloma, administering unrequired chemotherapy to patients, lying to them about the availability of alternative treatments, and ordering infusion times increased beyond what was medically necessary or advisable purely to increase his reimbursement.
The episode showed how there had been signs about his malpractice, which included a civil suit filed by a patient in 2007 and a veteran oncology nurse complaining to the state authorities in 2010. However, Farid’s schemes began to unravel in July 2013 when one of his 54-year-old patients, Monica Flagg, broke her leg and went to a suburban Detroit-area hospital for treatment. Farid, who had diagnosed her with multiple myeloma, was on vacation in Lebanon, and one of his doctors, Soe Maunglay, attended to Monica at MHO.
Soe could find no indication for the chemotherapy and supportive care medications. Reports stated he was already on notice after catching Farid lying about the clinic’s enrollment in a professional quality program. Suspicious, Soe began investigating some of Farid’s other cases, which included excessive use of rituximab and IVIG. During his probe, he contacted Farid’s practice manager, George Karadsheh, whose inspection supported Soe’s suspicions. George went to the Department of Justice and was interviewed on August 2, 2013.
The federal agents interviewed several staff members of MHO and corroborated the claims made by the whistleblowers — George and Soe. They arrested Farid and charged him with 19 counts of healthcare fraud and other crimes. Originally held on a $170,000 bond, the federal authorities discovered he and his wife had assets of $9 million not yet seized. Fearing him a flight risk, a federal judge raised Farid’s bond to $9 million. The Federal Bureau of Investigation confiscated thousands of medical charts.
They amassed evidence that he had used dishonest measures to trick the patients’ insurance companies and Medicare into paying $34 million in fraudulent and unnecessary claims. The officers also discovered that Farid took kickbacks from two local hospices and poured Medicare and private insurance proceeds into his diagnostic testing facility. They filed a 23-count indictment charging him with healthcare fraud, conspiracy to take and receive kickbacks, money laundering, and unlawfully procuring naturalization. Facing a maximum of 175 years in prison and the prospect of losing citizenship, Farid decided to take a plea deal.
He pled guilty in September 2014 to 16 federal charges — 13 counts of health care fraud, two counts of money laundering, and one count of conspiring to pay and receive kickbacks and cash payments for referring patients to a particular hospice and home health care company. He was sentenced to 45 years in federal prison and agreed to forfeit millions of dollars in assets to pay restitution to former patients or their families, approximately $17.6 million. The 58-year-old is incarcerated at Federal Correctional Institution, Williamsburg in South Carolina, and will not be released before December 2050.
What a saga. Who knew charisma/mystique could completely deceive so many people about their own health?
I also wonder how much he skewed regional/state cancer statistics. Is his fraud the reason Michigan has "hot spots" for certain types of cancer?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














